Reports and Records. 3.6.1 Licensee must deliver to Licensor within **** after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 6 contracts
Samples: License Agreement (AveXis, Inc.), License Agreement (AveXis, Inc.), License Agreement (REGENXBIO Inc.)
Reports and Records. 3.6.1 3.7.1 Licensee must deliver to Licensor within **** after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 6 contracts
Samples: License Agreement, License Agreement (AveXis, Inc.), License Agreement (REGENXBIO Inc.)
Reports and Records. 3.6.1 3.7.1 Licensee must deliver to Licensor within […**** …] after the end of each Calendar Quarter after the first commercial sale First Commercial Sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:: *** Confidential Treatment Requested ***
Appears in 5 contracts
Samples: Option and License Agreement, Option and License Agreement (Ultragenyx Pharmaceutical Inc.), Option and License Agreement (Dimension Therapeutics, Inc.)
Reports and Records. 3.6.1 Licensee must deliver to Licensor within [**** ] after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 5 contracts
Samples: License Agreement, License Agreement (Prevail Therapeutics Inc.), License Agreement (Audentes Therapeutics, Inc.)
Reports and Records. 3.6.1 3.5.1 Licensee must deliver to Licensor within **** after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 5 contracts
Samples: License Agreement (REGENXBIO Inc.), Confidential Treatment Requested Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.)
Reports and Records. 3.6.1 3.5.1 Licensee must deliver to Licensor within […**** …] after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 3 contracts
Samples: License Agreement (Ultragenyx Pharmaceutical Inc.), License Agreement (Dimension Therapeutics, Inc.), License Agreement (Dimension Therapeutics, Inc.)
Reports and Records. 3.6.1 3.7.1 Licensee must deliver to Licensor within **** after the end of each Calendar Quarter after the first commercial sale First Commercial Sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:: ****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. CONFIDENTIAL TREATMENT REQUESTED
Appears in 3 contracts
Samples: Option and License Agreement (REGENXBIO Inc.), Option and License Agreement (REGENXBIO Inc.), Option and License Agreement (REGENXBIO Inc.)
Reports and Records. 3.6.1 Licensee must deliver to Licensor within **** after the end of each Calendar Quarter after the first commercial sale First Commercial Sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar QuarterQuarter on a Licensed Product by Licensed Product basis, including:
Appears in 2 contracts
Samples: License Agreement (Abeona Therapeutics Inc.), License Agreement (REGENXBIO Inc.)
Reports and Records. 3.6.1 Licensee must deliver to Licensor within **** after the end end’ of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:: ****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. CONFIDENTIAL TREATMENT REQUESTED
Appears in 2 contracts
Samples: License Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.)
Reports and Records. 3.6.1 3.7.1 Licensee must deliver to Licensor within [**** ] after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 2 contracts
Samples: License Agreement (Audentes Therapeutics, Inc.), License Agreement (Audentes Therapeutics, Inc.)
Reports and Records. 3.6.1 3.9.1 Licensee must deliver to Licensor within [**** ] after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 1 contract
Reports and Records. 3.6.1 3.7.1 Licensee must deliver to Licensor within **** * * after the end of each Calendar Quarter beginning after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 1 contract
Reports and Records. 3.6.1 3.7.1 Licensee must deliver to Licensor within [**** ] after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar QuarterQuarter on a Licensed-Product by Licensed-Product basis, including:
Appears in 1 contract
Reports and Records. 3.6.1 3.7.1 Licensee must deliver to Licensor within [**** ] after the end of each Calendar Quarter after the first commercial sale of a Licensed Product a report setting forth the calculation of the royalties due to Licensor for such Calendar Quarter, including:
Appears in 1 contract
